Age of onset and clinical presentation of telomerase mutation carriers
Sex . | Age, y* . | First presentation . | Second feature(s) . | Family history† . | Mutation . |
---|---|---|---|---|---|
M | 9 | AA | Pulmonary fibrosis, liver fibrosis | Pulmonary fibrosis, liver cirrhosis | hTERT Lys902Arg |
M | 10 | AA | Pulmonary disease | Pulmonary fibrosis, liver disease | hTERT Val170Met |
F | 13 | AA | Pulmonary fibrosis | AA | hTERT Val1025Phe |
M | 14 | AA | Pulmonary fibrosis, liver cirrhosis | hTR 143 G→A | |
M | 18 | AA | Pulmonary fibrosis | hTERT Ala716Thr | |
F | 21 | AA | Pulmonary fibrosis, MDS | hTR 204 C→G | |
M | 44 | Pulmonary fibrosis‡ | Hypoplastic marrow | Pulmonary fibrosis | hTERT Val170Met |
F | 44 | Pulmonary fibrosis§ | Pancytopenia, macrocytosis | Pulmonary fibrosis, pancytopenia | hTERT Val747AlafsX20 |
M | 57 | Pulmonary fibrosis‡ | Hypoplastic marrow, liver disease | Pulmonary fibrosis | hTERT Leu841Phe |
F | 61 | Pulmonary fibrosis‡ | AA, pulmonary fibrosis | hTR 98 G→A |
Sex . | Age, y* . | First presentation . | Second feature(s) . | Family history† . | Mutation . |
---|---|---|---|---|---|
M | 9 | AA | Pulmonary fibrosis, liver fibrosis | Pulmonary fibrosis, liver cirrhosis | hTERT Lys902Arg |
M | 10 | AA | Pulmonary disease | Pulmonary fibrosis, liver disease | hTERT Val170Met |
F | 13 | AA | Pulmonary fibrosis | AA | hTERT Val1025Phe |
M | 14 | AA | Pulmonary fibrosis, liver cirrhosis | hTR 143 G→A | |
M | 18 | AA | Pulmonary fibrosis | hTERT Ala716Thr | |
F | 21 | AA | Pulmonary fibrosis, MDS | hTR 204 C→G | |
M | 44 | Pulmonary fibrosis‡ | Hypoplastic marrow | Pulmonary fibrosis | hTERT Val170Met |
F | 44 | Pulmonary fibrosis§ | Pancytopenia, macrocytosis | Pulmonary fibrosis, pancytopenia | hTERT Val747AlafsX20 |
M | 57 | Pulmonary fibrosis‡ | Hypoplastic marrow, liver disease | Pulmonary fibrosis | hTERT Leu841Phe |
F | 61 | Pulmonary fibrosis‡ | AA, pulmonary fibrosis | hTR 98 G→A |